Evaluation of Bleeding on Brushing Using Neem Extract Mouthwash Versus Chlorhexidine Mouthwash
Launched by CAIRO UNIVERSITY · May 24, 2017
Trial Information
Current as of May 02, 2025
Unknown status
Keywords
ClinConnect Summary
1. First , we will select the patients according to the inclusion criteria.
2. We will take sulcus bleeding index which is defined as an index of gingival inflammation in which bleeding is measured from four gingival units using a periodontal probe. The scoring is ranging around eight anterior teeth from 0 to 5.In this study, we will take only score 2 which is bleeding on probing, change in colour and no edema in order to reduce variability.
3. 2%neem extract will be used to prepare mouthwash while, chlorhexidine will be used as positive control.
4. Chlorhexidine will be coded with the lett...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Children aged 8-10 years old with gingivitis
- • 2. cooperative children
- • 3.both genders
- • 4.medically free
- • 5. sulcus bleeding index score is 2
- Exclusion Criteria:
- • 1. Children undergoing orthodontic treatment
- • 2.Children undergoing any other oral hygiene aid other than routine teeth brushing
- • 3.Children with known history of allergy to any mouthwash or drug
- • 4.Parents unable to give informed consent
- • 5.Children taking antibiotic or antiseptic in previous two months
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Sherif B Eltaweel, Ass. prof
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials